A.V. DUBOVAYA¹, Yu.V. NAUMENKO^{1, 2}

¹M. Gorky Donetsk National Medical University, Donetsk

²V.K. Gusak Institute of Urgent and Regenerative Surgery, Donetsk

  Contact:

Dubovaya A.V. ― MD, Professor of the Department of Propaedeutics in Pediatrics

Address: 16 Ilyich Avenue, 283003, Donetsk, Ukraine, e-mail: [email protected]

 The article presents the results of evaluating the effectiveness of vitamin D₃ aqueous solution in the complex treatment of children with essential arterial hypertension. Vitamin D₃ was administered enterally as an aqueous solution of cholecalciferol for 3 months once every day in the dose of 1500 IU under the initial decrease of 25(OH)D level in blood plasma. The positive effect of the drug was proved, which consists in restoring the normal content of 25 (OH)D in blood plasma and reducing systolic blood pressure.

Key words: adolescents, vitamin D deficiency; essential arterial hypertension.

(For citation: Dubovaya A.V., Naumenko Yu.V. Evaluation of cholecalciferol effectiveness in the complex treatment of essential arterial hypertension in children. Practical Medicine. 2020. Vol. 18, № 1, P. 93-97)

REFERENCES

1. Gupta V. Vitamin D: Extra-skeletal effects. J. Med. Nutr. Nutraceut, 2012, no. 1, pp. 17-26. https://doi.org/10.4103/2278-019X.94632
2. Pereira-Santos M., Costa P.R., Santos C.A. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes. Rev, 2016, no. 17(5), p. 484. https://doi.org/ 10.1111/ obr.12393
3. Dubovaya A.V. The effect of vitamin D on the occurrence and progression of diseases of the cardiovascular system (literature review). Krymskiy terapevticheskiy zhurnal, 2016, no. 4 (31), pp. 13-18 (in Russ.).
4. Povoroznyuk V.V. et al. The value of vitamin D in the pathogenesis of cardiovascular diseases. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta, 2015, no. 2, pp. 6-14 (in Russ.).
5. Zeyd S.S.K., Yakovleva L.V. Assessment of vitamin D status in adolescent children with primary arterial hypertension. Ekologiya cheloveka, 2017, no. 5, pp. 38-41 (in Russ.).
6. Dubovaya A.V., Sukhareva G.E. Assessment of vitamin D status in adolescent children with primary arterial hypertension. Nauchnye vedomosti BelGU. Seriya Meditsina. Farmatsiya, 2017, no. 5 (254), no. 37, pp. 45-51 (in Russ.).
7. Golzarand M., Shab-Bidar S., Koochakpoor G. Effect of vitamin D3 supplementation on blood pressure in adults: an updated meta-analysis. Nutr. Metab. Cardiovask. Dis, 2016, no. 26 (8), pp. 663-673. https://doi.org/10.1016/j.numecd.2016.04.011
8. Li Y.C., Kong J., Wei M. et al. 1,25-Dihydroxyvitamin (D)3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest, 2002, no. 110, pp. 229-238.
9. Motiwalaa S.R., Wang T.J. Vitamin D and cardiovascular disease. Current Opinion in Nephrology and Hypertension, 2017, no. 20, pp. 345-353.
10. Rossiyskaya assotsiatsiya endokrinologov FGBU “Endokrinologicheskiy nauchnyy tsent”, 2015 [Russian Association of Endocrinologists FSBI “Endocrinological Research Center”, 2015].
11. Lyakh Yu.E., Gur’yanov V.G. Mathematical modeling in solving classification problems in biomedicine. Ukrainskiy zhurnal telemeditsiny i meditsinskoy telematiki, 2013, vol. 10, no. 2, pp. 69-76 (in Russ.).
12. Zakirova A.M., Mal’tsev S.V. Provision of vitamin D for children from the group of medical and social risk. Prakticheskaya meditsina, 2017, no. 5, pp. 36-40 (in Russ.).